Your browser doesn't support javascript.
loading
HDAC-an important target for improving tumor radiotherapy resistance.
Ling, Rui; Wang, Jingzhi; Fang, Yuan; Yu, Yunpeng; Su, Yuting; Sun, Wen; Li, Xiaoqin; Tang, Xiang.
Affiliation
  • Ling R; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Wang J; Department of Radiotherapy Oncology, Affiliated Yancheng First Hospital of Nanjing University Medical School, First People's Hospital of Yancheng, Yancheng, China.
  • Fang Y; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Yu Y; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Su Y; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Sun W; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Li X; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
  • Tang X; Department of Oncology, Affiliated Hospital of Jiangsu University, Zhenjiang, China.
Front Oncol ; 13: 1193637, 2023.
Article in En | MEDLINE | ID: mdl-37503317

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Front Oncol Year: 2023 Document type: Article Affiliation country: Country of publication: